Skip to content
Disclosery

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 34 holding rows worth $86,228,809.

Accession
0001104659-25-048878
Filer
CIK 1582844
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 34 entries on the cover page, a total value of $86,228,809 stated on the cover page (in dollars after the unit check, H1), rows summing to $86,228,809 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
OCULAR THERAPEUTIX INC67576A100COM1,219,724$8,940,577dollars as filed
INSMED INC COM PAR $.01457669307Stock106,074$8,092,385dollars as filed
Tourmaline Bio Inc89157D105Common Stock426,882$6,492,875dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN3,410,402$6,070,516dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock265,269$5,220,494dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock785,961$4,943,695dollars as filed
SOLENO THERAPEUTICS INC834203309COM67,136$4,796,867dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR7,023$4,156,668dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR23,340$3,637,772dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW87,141$3,300,030dollars as filed
CIDARA THERAPEUTICS INC171757206COM NEW125,708$2,707,750dollars as filed
OCULIS HOLDING AGH5870P102CMN125,000$2,378,750dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock66,662$2,357,168dollars as filed
LIQUIDIA CORPORATION COM NEW53635D202Stock153,482$2,263,860dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK59,748$2,155,110dollars as filed
HELIX ACQUISITION CORP IIG4444H101CL A ORD SHS187,257$2,116,004dollars as filed
Merck & Co.,Inc.58933Y105COM22,994$2,063,941dollars as filed
SURROZEN INC86889P208COMMON STOCK170,000$1,982,200dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM85,454$1,879,988dollars as filed
MEREO BIOPHARMA GROUP PLC589492107CMN791,815$1,781,584dollars as filed
UNICYCIVE THERAPEUTICS INC90466Y103CMN2,352,887$1,352,675dollars as filed
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock9,575$1,188,736dollars as filed
VERASTEM INC92337C203COMMON STOCK176,000$1,061,280dollars as filed
Gilead Sciences,Inc.375558103COM9,298$1,041,841dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock325,550$898,518dollars as filed
ZYMEWORKS INC98985Y108COM68,459$815,347dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM21,290$770,911dollars as filed
VERVE THERAPEUTICS INC92539P101COM162,724$743,649dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM83,350$555,945dollars as filed
RAPPORT THERAPEUTICS INC COM75383L102Stock16,400$164,492dollars as filed
FORTE BIOSCIENCES INC34962G208COMMON STOCK18,469$143,319dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM45,456$136,368dollars as filed
NUVATION BIO INC67080N119WARR90,832$17,494dollars as filed
ENLIVEN THERAPEUTICS INC452CVR012COM115,805$0dollars as filedValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-25-048878this filing2025-05-15acceptance time not in the bulk data set